VANCOUVER, British Columbia, Jan. 3, 2019 /PRNewswire/ — Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) (“LDS” or the “Company”) announces that Core Isogenics Inc., the Company’s wholly-owned subsidiary focused on developing isogenic seed strains and automated cultivation methods for the cannabis industry (“Core Isogenics”), was issued both a Temporary Nursery License and a Cultivation License by the Bureau of Cannabis Control of California (the “Temporary Licenses”).
The Temporary Licenses issued to Core Isogenics will allow the Company to complete its business model gaining complete control of its infrastructure, including all aspects of genetics, cultivation, formulation, manufacturing, and distribution of its products including its patent-pending CannaStrips™.
The Nursery License allows Core Isogenics to develop its plant genetics technology and produce seeds with identical properties to those used in CannaStrips™ formula, thereby reducing the number of extraction steps that currently are required to extract ingredients from more than one plant, instead extracting from a single plant with the exact ingredients already in its DNA.
The Nursery will utilize the seeds grown based on the Core Isogenics process. These seeds will be grown inside the Company’s climate-controlled, negatively-pressurized, and remotely-monitored rooms to ensure contaminant-free plant development. The Company is planning to develop both indoor and outdoor strains with a focus on future large outdoor cultivations.
The Cultivation License will allow the Company to utilize its current facility by taking the seedlings from the nursery to the Company’s automated growing environment. The automated cultivation environment will maximize plant growth and shorten grow cycles in an optimized cultivation area by utilizing the Company’s proprietary Flexible Path technology of single aisle movable plant beds for the most efficient use of space.
Lifestyle Delivery Systems Inc.’s CEO, Brad Eckenweiler, stated, “These licenses complete our business model foundation. The issuance of these licenses allows the Company to control the complete product development stream from genetic composition of bio-mass to distribution of the highest quality products with precise ingredients. These results will now be obtainable whether the plant bio-mass is from Core Isogenics’ cultivation or from contract growers.”
The Company will continue its development of processes and product lines as well as building a distribution network.